期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

SPECT/CT图像融合在分化型甲状腺癌^(131)I治疗后的临床应用价值 被引量：1

Clinical application value of fusion images of SPECT/CT in patients with differentiated thyroid carcinoma after ^(131)I therapy
下载PDF
导出
摘要 目的探讨SPECT/CT图像融合在分化型甲状腺癌术后患者131I治疗后判断残余组织和转移灶的存在部位,并在确定治疗方案中的应用价值。方法对分化型甲状腺癌(DTC)术后患者30例(60例次)于131I治疗后5~7天行SPECT/CT全身和局部断层显像。131I治疗剂量为100~200mCi。结果DTC术后患者131I治疗行SPECT/CT融合图像显示:单纯残留甲状腺组织摄取131I37次,残余甲状腺和颈部淋巴结16次,纵膈和颈部淋巴结2次,双肺弥漫性及散在病灶1次,右锁骨上淋巴结1次,残余甲状腺和双肺转移2次,残余甲状腺组织和骨骼转移1次。结论SPECT/CT图像融合在131I治疗DTC后提高病灶的定位诊断、制定和调整治疗方案方面具有重要的应用价值。 Objective To investigate the clinical application value of the fusion of SPECT/CT images in patients with differentiated thyroid carcinoma(DTC)after operation and 131I therapy.Methods Thirty patients of(60 times)DTC after thyroidectomy were studied using SPECT/CT images after operation and after 131I therapy 5-7 days.The therapy dosagedosagedosagedosage of 131I were 100-200 mCi.Results The result of 131I SPECT/CT fusion images showed 37 times.Radioiodine were concentrated in the remains of thyroid gland.Six...
作者 林天生 陈为民 王申
机构地区 福建医科大学附属协和医院核医学科
出处 《中国医学影像技术》 CSCD 北大核心 2008年第S1期202-204,共3页 Chinese Journal of Medical Imaging Technology
关键词 SPECT/CT图像融合 甲状腺肿瘤 ^(131)I治疗 SPECT/CT fusion images Thyroid neoplasms ^（131）I therapy
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献1

二级参考文献8

  • 1陈盛祖.关于PET/CT与分子影像学[J].中华核医学杂志,2003,23(S1):11-12. 被引量：14
  • 2Bakheet SM,Hammami MM.Patterns of radioiodine uptake by the lactating breast[J].Eur J Nucl Med, 1994,21(7):604-608.
  • 3Mitchell G,Pratt BE,Vini L,et al.False positive 131I whole body scans in thyroid cancer[J].Br J Radiol, 2000,73(870):627-635.
  • 4Chung JK,Park YJ,Kim TY,et al.Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation[J].Clin Endocrinol (Oxf), 2002,57(2):215-221.
  • 5Lind P,Kresnik E,Kumnig G, et al.18F-FDG-PET in the follow-up of thyroid cancer[J].Acta Med Austriaca, 2003,30(1):17-21.
  • 6Hsu CH,Liu RS,Wu CH,et al.Complementary role of 18F-fluorodeoxyglucose positron emission tomography and 131I scan in the follow-up of post-therapy differentiated thyroid cancer[J].J Formos Med Assoc,2002,101(7):459-467.
  • 7Lind P,Kresnik E,Kumnig G,et al.18F-FDG-PET in the follow-up of thyroid cancer[J].Acta Med Austriaca, 2003,30(1):17-21.
  • 8Tian R, Kuang AR, Qin WS, et al.Value of post therapy whole body 131I scan in the evaluation of patients with differentiated thyroid cancer[J].Chinese Journal of Nuclear Medicine, 2000, 20(4):162-164.田蓉,匡安仁,秦卫仕,

共引文献10

同被引文献23

  • 1袁耿彪,匡安仁.钠碘转运体与分化型甲状腺癌[J].中国介入影像与治疗学,2005,2(1):6-9. 被引量：3
  • 2American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association man- agement guidelines for patients with thyroid nodules and differen- tiated thyroid cancer. Thyroid, 2009,19(11):1167-1214.
  • 3Glazer DI, Brown RK, Wong KK, et al. SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: Pearls and pitfalls in image interpretation. Radiographics, 2013, 33 (2) : 397-418.
  • 4Wong KK, Zarzhevsky N, Cahill JM, et al. Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma. Br J Radiot, 2009,82(982) : 860-876.
  • 5Grewal RK, Tuttle RM, Fox J, et al. The effect of posttherapy 1-131 SPECT/CT on risk classification and management of pa- tients with differentiated thyroid cancer. J Nucl Med, 2010, 51 (9) : 1361-1367.
  • 6Mustafa M, Kuwert T, Weber K, et al. Regional lymph node in- volvement in T1 papillary thyroid carcinoma: A bicentric prospec- tive SPECT/CT study. Eur J Nucl Med Mol Imaging, 2010, 87 (8) : 1462-1466.
  • 7Schmidt D, Linke R, Uder M, et al. Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by 1-131-SPECT/CT at the first radioablation. Eur J Nuel Med Mol Imaging, 2010, 37 (4):699-705.
  • 8Haveman JW, Phan HT, Links TP, et at. Implications of medi- astinal uptake of 131i with regard to surgery in patients with dif- ferentiated thyroid carcinoma. Cancer, 2005,103(1) :59-67.
  • 9Omiar O, Akgian A, Ozcan Z, et al. Clinical implications of dif- fuse hepatic uptake observed in postablative and post-therapeutic 1-131 scans. Clin Nucl Med, 2009,34(1):11-14.
  • 10Qiu ZL, Xue YL, Song H J, et al. Comparison of the diagnostic and prognostic values of Tc-99m-MDP-planar bone scintigraphy, 1-131-SPECT/CT and F-18-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Nucl Med Commun, 2012,33(12) : 1232-1242.

引证文献1

二级引证文献1

中国医学影像技术
2008年 第S1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部